3/27
03:06 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at UBS Group AG from $110.00 to $101.00. They now have a "neutral" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at UBS Group AG from $110.00 to $101.00. They now have a "neutral" rating on the stock.
3/26
11:50 am
bntx
This Vaccine Maker Sits on Cash Almost Equal to Its Market Value [Yahoo! Finance]
Low
Report
This Vaccine Maker Sits on Cash Almost Equal to Its Market Value [Yahoo! Finance]
3/25
07:30 am
bntx
BioNTech gets US agency notice over default on COVID vaccine royalties [Reuters]
Low
Report
BioNTech gets US agency notice over default on COVID vaccine royalties [Reuters]
3/25
06:58 am
bntx
UPDATE 1-BioNTech gets notice from US agency over default on COVID vaccine royalties [Yahoo! Finance]
Low
Report
UPDATE 1-BioNTech gets notice from US agency over default on COVID vaccine royalties [Yahoo! Finance]
3/24
09:18 am
bntx
BioNTech Full Year 2023 Earnings: Misses Expectations [Yahoo! Finance]
Low
Report
BioNTech Full Year 2023 Earnings: Misses Expectations [Yahoo! Finance]
3/23
09:12 am
bntx
Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts [Yahoo! Finance]
Low
Report
Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts [Yahoo! Finance]
3/22
01:47 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $99.00 to $90.00. They now have an "underweight" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $99.00 to $90.00. They now have an "underweight" rating on the stock.
3/21
01:42 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at BMO Capital Markets from $127.00 to $123.00. They now have an "outperform" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at BMO Capital Markets from $127.00 to $123.00. They now have an "outperform" rating on the stock.
3/21
11:46 am
bntx
BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/21
11:43 am
bntx
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $171.00 price target on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $171.00 price target on the stock.
3/20
05:02 pm
bntx
US STOCKS-Wall St ends higher as Fed keeps three rate cuts on the horizon [Yahoo! Finance]
Low
Report
US STOCKS-Wall St ends higher as Fed keeps three rate cuts on the horizon [Yahoo! Finance]
3/20
04:05 pm
bntx
US STOCKS-Wall St advances as US Fed keeps three rate cuts on the horizon [Yahoo! Finance]
Low
Report
US STOCKS-Wall St advances as US Fed keeps three rate cuts on the horizon [Yahoo! Finance]
3/20
03:45 pm
bntx
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials [Yahoo! Finance]
Neutral
Report
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials [Yahoo! Finance]
3/20
02:51 pm
bntx
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/20
02:48 pm
bntx
BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions [Seeking Alpha]
Neutral
Report
BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions [Seeking Alpha]
3/20
11:13 am
bntx
BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline [Yahoo! Finance]
Low
Report
BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline [Yahoo! Finance]
3/20
08:20 am
bntx
Bitcoin's Slump Is the First Test for ETF Enthusiasm, What's Next for Cryptos. And 5 Other Things to Know Before Markets Open. [Yahoo! Finance]
Low
Report
Bitcoin's Slump Is the First Test for ETF Enthusiasm, What's Next for Cryptos. And 5 Other Things to Know Before Markets Open. [Yahoo! Finance]
3/20
07:08 am
bntx
Pfizer partner BioNTech ekes out Q4 profit despite 65% revenue drop [Seeking Alpha]
Low
Report
Pfizer partner BioNTech ekes out Q4 profit despite 65% revenue drop [Seeking Alpha]
3/20
06:59 am
bntx
BioNTech shifts focus toward cancer drug development after earnings, revenue plunge [Globe and Mail, The (Toronto, Canada)]
Low
Report
BioNTech shifts focus toward cancer drug development after earnings, revenue plunge [Globe and Mail, The (Toronto, Canada)]
3/20
06:27 am
bntx
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update [Yahoo! Finance]
Low
Report
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update [Yahoo! Finance]
3/20
06:21 am
bntx
After earnings plunge, BioNTech pins hopes on cancer drug launches [Reuters]
Low
Report
After earnings plunge, BioNTech pins hopes on cancer drug launches [Reuters]
3/20
06:20 am
bntx
After earnings plunge, BioNTech pins hopes on cancer drug launches [Yahoo! Finance]
Low
Report
After earnings plunge, BioNTech pins hopes on cancer drug launches [Yahoo! Finance]
3/20
06:15 am
bntx
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Medium
Report
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
3/20
06:12 am
bntx
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer [Yahoo! Finance]
Medium
Report
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer [Yahoo! Finance]
3/20
06:00 am
bntx
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Medium
Report
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer